MacroGenics
MGNX
#9393
Rank
โ‚ฌ74.43 M
Marketcap
1,18ย โ‚ฌ
Share price
-0.72%
Change (1 day)
-63.26%
Change (1 year)

MacroGenics (MGNX) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : โ‚ฌ0.17 Billion

According to MacroGenics's latest financial reports the company's total liabilities are โ‚ฌ0.17 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

MacroGenics - Total liabilities on balance sheet (from 2012 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚ฌ0.13 B6.08%
2023-12-31โ‚ฌ0.13 B2.19%
2022-12-31โ‚ฌ0.12 B52.86%
2021-12-31โ‚ฌ84.43 M25.34%
2020-12-31โ‚ฌ67.36 M-7.83%
2019-12-31โ‚ฌ73.08 M-6.32%
2018-12-31โ‚ฌ78.01 M25.41%
2017-12-31โ‚ฌ62.21 M53.93%
2016-12-31โ‚ฌ40.41 M-3.79%
2015-12-31โ‚ฌ42 M-2.87%
2014-12-31โ‚ฌ43.24 M27.44%
2013-12-31โ‚ฌ33.93 M-27.58%
2012-12-31โ‚ฌ46.85 M-24.09%
2011-12-31โ‚ฌ61.72 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Xencor
XNCR
โ‚ฌ0.20 B 19.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ99.31 B 56,650.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ66.68 B 38,002.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚ฌ31.84 B 18,096.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ69.16 B 39,417.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ78.23 B 44,601.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ67.24 B 38,321.79%๐Ÿ‡บ๐Ÿ‡ธ USA